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a b s t r a c t
Thioredoxin reductase (TR) catalyzes the reduction of thioredoxin (TRX), which in turn reduces
mammalian typical 2-Cys peroxiredoxins (PRXs 1–4), thiol peroxidases implicated in redox homeostasis
and cell signaling. Typical 2-Cys PRXs are inactivated by hyperoxidation of the peroxidatic cysteine to
cysteine-sulﬁnic acid, and regenerated in a two-step process involving retro-reduction by sulﬁredoxin
(SRX) and reduction by TRX. Here transient exposure to menadione and glucose oxidase was used to
examine the dynamics of oxidative inactivation and reactivation of PRXs in mouse C10 cells expressing
various isoforms of TR, including wild type cytoplasmic TR1 (Sec-TR1) and mitochondrial TR2 (Sec-TR2)
that encode selenocysteine, as well as mutants of TR1 and TR2 in which the selenocysteine codon was
changed to encode cysteine (Cys-TR1 or Cys-TR2). In C10 cells endogenous TR activity was insensitive to
levels of hydrogen peroxide that hyperoxidize PRXs. Expression of Sec-TR1 increased TR activity, reduced
the basal cytoplasmic redox state, and increased the rate of reduction of a redox-responsive cytoplasmic
GFP probe (roGFP), but did not inﬂuence either the rate of inactivation or the rate of retro-reduction of
PRXs. In comparison to roGFP, which was reduced within minutes once oxidants were removed
reduction of 2-Cys PRXs occurred over many hours. Expression of wild type Sec-TR1 or Sec-TR2, but
not Cys-TR1 or TR2, increased the rate of reduction of PRXs and improved cell survival after menadione
exposure. These results indicate that expression levels of TR do not reduce the severity of initial oxidative
insults, but rather govern the rate of reduction of cellular factors required for cell viability. Because Sec-
TR is completely insensitive to cytotoxic levels of hydrogen peroxide, we suggest TR functions at the top
of a redox pyramid that governs the oxidation state of peroxiredoxins and other protein factors, thereby
dictating a hierarchy of phenotypic responses to oxidative insults.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Introduction
Cellular oxidants modulate the strength and duration of signal-
ing through redox-responsive pathways that govern cell prolifera-
tion and survival [1,2]. In many disease states management of
endogenous and/or exogenous oxidants may be compromised,
leading to oxidative stress, damage to macromolecules and loss of
cell viability. Phenotypic adaptation to chronic oxidative stress,
which occurs in many cancers, often involves up-regulation of
stress response proteins and antioxidant enzymes, leading to
improved cell survival [3]. Among the families of antioxidant
enzymes that are often over-expressed in cancer and other disease
states are thioredoxin reductases (TRs) and peroxiredoxins (PRXs),
both of which are involved in the metabolism of hydrogen peroxide
[4]. Mammalian TRs are a family of selenocysteine-containing
oxidoreductases that act as the primary reductases for thioredoxin
(TRX) in a NADPH dependent reaction [4,5]. Recent studies
show that selenocysteine in the C-terminal redox center renders
mitochondrial TR insensitive to inactivation from oxidants [6],
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suggesting TR and other selenoenzymes may mediate resistance to
oxidative stress.
Malignant mesotheliomas express elevated levels of TR1 [7,8]
and mesothelioma cells propagated in vitro have higher levels of
TR activity than untransformed mesothelial cells do [9]. Given that
this phenotype has been observed in many other tumor types, TR
has emerged as an attractive therapeutic target in human malig-
nancies [10,11]. Because of the limited number of cellular proteins
that contain selenocysteine, one approach is to use compounds
(such as aurothioglucose and auranoﬁn) that selectively target
selenocysteine [12–14]. However, the effects of inhibition or
over-expression of TR on cell growth and survival are not straight-
forward, as expression of TR in which the activity of selenium
is compromised may induce cell death due to pro-oxidant activity
[15]. TR and TRX have been shown to inﬂuence the activity of
transcription factors, kinases and other factors in cell signaling
circuits, and in some contexts the pro-proliferative role of its
primary substrate thioredoxin (TRX) has been ascribed to the
regulation of the ERK pathway leading to the expression of cyclin
D1 [16].
Peroxiredoxins are a family of thiol peroxidases that are
ubiquitously expressed throughout eukaryotes. In mammals there
are six family members, with peroxiredoxins 1–4 representing
typical 2-Cys PRXs; these enzymes function as head-to-tail homo-
dimers with two reaction sites, each consisting of a peroxidatic
cysteine in one monomer and a resolving cysteine in the opposing
subunit [17]. During the metabolism of hydrogen peroxide the
initial step in the peroxiredoxin reaction cycle is oxidation of the
peroxidatic cysteine to sulfenic acid (–SOH), which then sponta-
neously reacts with the resolving cysteine in the opposing subunit
to produce an intermolecular disulﬁde bond. The intermolecular
disulﬁde bond then is reduced by thioredoxin, which in turn is
reduced by TR, using reducing equivalents from NADPH. The
peroxidatic cysteines of 2-Cys PRXs are among the most reactive
cysteines in the cell [18], in part due to the stabilization of the
thiolate in the active site and structural interactions positioning
peroxide for attack [19–21]. Curiously, an evolutionarily conserved
carboxy-terminal extension on PRXs 1–4 stabilizes the peroxidatic
SOH intermediate, making it susceptible to further attack by
hydrogen peroxide, thereby leading to the formation of sulﬁnic
acid (–SOOH). This process, which has been termed “over-oxida-
tion” or “hyperoxidation”, precludes disulﬁde bond formation and
would be expected to permanently inactivate the enzyme, for
sulﬁnic acid residues in proteins generally are not repaired. PRXs
are a notable exception, for with the aid of ATP the reductase
sulﬁredoxin (SRX) is capable of “retro-reduction” of PRX-SOOH
and regeneration of enzyme activity [22,23]. In addition to homo-
dimers, the oxidation state of PRXs inﬂuences their relative
distribution in dimers, decamers and higher order oligomers that
have chaperone and other functions [24]. The unusual features of
PRX catalysis and oligomerization, as well as their interaction with
many cellular regulatory factors, have led to proposals that PRXs
act as peroxide sensors in which structural transitions and/or
changes in protein–protein interactions with cellular regulators
modulate responses to oxidative stress [25,26]. In yeast, the TR
system is devoted to metabolism of hydrogen peroxide [27], and
regulation of hierarchical responses to oxidative insults by thiol
peroxidase Tsa1 has been elegantly dissected [28,29]. However,
detailed descriptions of similar hierarchical pathways in mamma-
lian cells have yet to be reported.
Both TR and PRXs may be over-expressed in cancer, and studies
in which TR has been down-regulated by RNA interference
strongly support the hypothesis that elevated expression of TR
promotes tumor cell proliferation in culture and tumor progres-
sion in animal models [30,31]. To mimic the situation often
encountered in malignancies, we have expressed cytoplasmic
TR1 and mitochondrial TR2 in mouse lung epithelial C10 cells that
are immortalized but not tumorigenic. Previously we described
the relationship between the oxidation state of PRX2 and C10 cell
cycle progression in response to ﬂuxes of hydrogen peroxide, and
showed that expression of cyclin D1 and cell cycle progression was
not recovered after oxidative insult until PRX2 was completely
reduced [32]. However, in contrast to PRXs, mammalian TRs with
selenocysteine in the C-terminal catalytic site are remarkably
resistant to inactivation by hydrogen peroxide and other oxidants
in vitro [6], raising the possibility that TR sits at the top of a redox
pyramid that includes peroxiredoxins as exquisitely sensitive
detectors of cellular peroxide.
To test this possibility, we compared the ability of TRs encoding
selenocysteine in the C-terminal redox center to TRs in which the
codon for selenocysteine had been changed to that for cysteine to
mediate recovery from oxidative insults. Our data suggest that TR
levels do not directly inﬂuence the extent of the initial insult, but
rather dictate the rate of recovery and cell viability, restoring
proliferative capacity over time. Moreover, only wild type TRs had
the capacity to improve cell survival, indicating that the insensi-
tivity of selenocysteine to inactivation by hydrogen peroxide is an
important feature of mammalian TRs.
Materials and methods
Cell culture
C10 mouse lung epithelial cells were maintained in CMRL cell
culture media (Corning Cellgro, Manassas, VA), supplemented
with 10% fetal bovine serum (FBS), 200 mM glutamine, and
0.5% penicillin streptomycin and propagated in a humidiﬁed
incubator at 37 1C and 5% CO2. Cells were trypsinized and re-
plated to obtain 75% conﬂuence on the following day for all
subsequent experiments.
Molecular cloning
Full length human TR1 was ampliﬁed from pCMV6-XL4 vector
by PCR using speciﬁc forward (TR1: 50-GAAAGTCGAGGAGACAGT-
TAAGCATG-30) and reverse (TR1: 50-CACAAGGAAAGGTCATGC-
TAAAACTG-30) primers and subsequently cloned into pcDNA
3.1 mammalian expression vector (Promega, Madison WI). Full
length cDNA for human TR2 was recovered from pCMV6-XL4 by
digestion with XbaI and EcoRI, puriﬁed by gel electrophoresis, and
ligated into linear pcDNA 3.1 using T4 DNA Ligase. Insertion of
wild type Sec-TR1 and Sec-TR2 full-length cDNAs, including the
30 SECIS elements, into pcDNA 3.1 was conﬁrmed by sequencing
using the appropriate forward and reverse primer sets (T7 For-
ward: BGH Reverse). PCR-based mutagenesis was performed by
Mutagenex (Piscataway, NJ) to replace the Sec codon with Cys and
was conﬁrmed by sequencing. Expression vectors for human TRX1
and TRX 2 were purchased from Open Biosystems (Thermo
Scientiﬁc, Waltham, MA). Expression vectors for cytosolic and
mitochondrial targeted roGFPs were a kind gift from J.A. Melendez
(College of Nanoscale Science and Engineering, Albany, NY).
Plasmid transfection and siRNA silencing
Plasmid expression vectors were introduced into C10 cells by
transfection or co-transfection using Lipofectamine 2000™ follow-
ing the manufacturer's guidelines (Invitrogen, Grand Island, NY).
Pilot experiments with GFP and RFP expression vectors showed
co-transfection efﬁciency with Lipofectamine 2000™ in C10 cells
was 90% or better (data not shown). Speciﬁc siRNA to TR1 (si-TR1,
50-CCAUAGAGGGCGAAUUUAAUU-30) was introduced into C10
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cells using Dharmafect™ following the manufacturer's guidelines
(Dharmacon, Thermo Scientiﬁc).
Live cell imaging with roGFP
Cells were transfected with indicated expression vectors in
combination with either cytosolic (Cyto-roGFP) or mitochondrial
targeted (Mito-roGFP) dynamic oxidant sensors [33]. Eighteen
hours after transfection cells were re-plated into 35-mm glass
bottom imaging dishes (MatTek™, Ashland, MA). The following
day media was changed to imaging media (20 mM HEPES, 134 mM
NaCL, 5.4 mM KCL, 1 mM MgSO4, 1.8 mM CaCl2, 5 mM glucose pH
7.4) and dishes were mounted on a Nikon Ti-E inverted micro-
scope. Images were collected and oxidation state was determined
as previously described [34]. Brieﬂy, ﬂuorescence emission was
collected at 525 nm after sequential excitation at 405 nm and
488 nm. The ratio of oxidized (emission after excitation at
405) to reduced (emission after excitation at 488 nm) roGFP
probe, after subtraction of background for each channel, is
presented as a measure of relative redox status of the cytosol
(Cyto-roGFP) or the mitochondria (Mito-roGFP). The change in
oxidation (ΔOx) of roGFP was determined by calculating the
change in the ratio 10 min after removal of menadione.
Detection of oxidant levels by DCF
Post-transfection, cells were plated into ﬂat-bottom 96 well
tissue culture plates, allowed to adhere and treated as indicated in
the text in complete media. The following day cells were washed
2 with pre-warmed HBSS plus calcium and magnesium and
incubated with HBSS containing 20 uM 20,70-dichlorodihydroﬂuor-
escein diacetate (DCF). After a 30 min incubation, DCF was
removed and the cells were washed 2 with HBSS and ﬂuores-
cence intensity was determined using a Synergy HT Microplate
Reader™ with excitation at 495 nm and emission at 525 nm.
Thioredoxin reductase activity assay
Thioredoxin reductase activity was determined in whole cell
lysates using the SC-TR assay as previously described [35]. Brieﬂy,
cells were grown to 75% conﬂuence, treated as indicated in the
text, and lysed on ice in NP-40 lysis buffer (150 mM NaCl, 50 mM
Tris pH 8.0, 1% NP-40, 1 mg/mL leupeptin, 1 mg/mL aprotinin,
1 mM NaF, 1 mM NaVO3, 1 mM PMSF). Lysates were cleared by
centrifugation at 14,000 rpm and total protein amount was deter-
mined by reading the absorbance of Bradford reagent at 595 nm.
Equal protein amounts (25 μg) were added to individual wells
of a clear round bottom 96 well microplate. Master mix containing
1 mM NADPH, and 2 mM selenocystine in ddH2O were added to
each well, yielding a ﬁnal concentration of 400 μM and 800 μM,
respectively. The conversion of NADPH to NADPþ was monitored
in 30 s intervals over a 20 min time period at 340 nm on a Synergy
HT Microplate Reader™ (BioTek). TR activity was determined
by comparing the initial slopes of NADPH oxidation for each
experimental condition and expressed as nmoles NADPH
min1mg1 of protein lysate using an extinction coefﬁcient of
6220 M1 cm1.
Immunoblotting
Equal amounts of protein sample (15–35 ug/lane) were separated
on 12% gels by SDS-PAGE and transferred to PVDF membrane.
Membranes were blocked in 5% milk (Tris-buffered saline with
0.2% Tween-20, TBST) for 1 h at room temperature. Primary
antibodies were diluted in 5% milk/TBST and incubated for 1 h at
room temperature. Anti-TR1 (1:2000), anti-Trx1 (1:2000), anti-Trx2
(1:2000) were purchased from Santa Cruz Biotechnology (Dallas,
TX). Anti-TR2 (1:2000), anti-PRX3 (1:2000), anti-PRX2 (1:2000),
and anti-PRX-SO2/SO3H (1:2000) were purchased from ABFrontier
(Seoul, Korea). Anti-actin antibody (1:5000) was from Millipore
(Billerica, MA). The membranes were washed for 5 min with fresh
TBST and washed in this manner 5 , after which the membranes
were incubated with appropriate species of horseradish peroxidase
conjugated secondary antibody (Millipore) diluted in 5% milk/TBST
for 1 h at room temperature. The membranes were again washed
5 (5 min each) with TBST and protein bands were visualized
with Enhanced Chemiluminescent™ detection system (Millipore).
Cell viability assays
Post transfection, cells were plated into ﬂat bottom 96-well
tissue culture plates, allowed to adhere, and treated as indicated in
the text in complete media. The following day wells were rinsed
2x with phosphate buffered saline (PBS) and ﬁxed in 3.4%
paraformaldehyde for 10 min and washed 1 in PBS. Viable cells
were stained with 0.1% crystal violet dissolved in ddH2O for
30 min and then rinsed sufﬁciently with water and allowed to
dry. Crystal violet was solubilized by addition of 100% methanol
and absorbance was read at 540 nm on a Synergy HT Microplate
Reader™.
Statistics
Statistical signiﬁcance was determined using the Students t-
test (two-tailed, unpaired). The data within is presented as the
mean þ/S.D. of 3 replicates unless otherwise stated and the
level of signiﬁcance is described in the ﬁgure legends.
Results
Previously we characterized the responses of mouse lung
epithelial C10 cells to oxidative insults in regard to cell cycle
arrest and recovery [1,36,37] and demonstrated that after arrest
expression of cyclin D1 and cell proliferation does not resume until
hyper-oxidized PRXs are reduced and high-molecular oligomers of
PRX2 are resolved to decamers and dimers [32]. C10 cells were
chosen as model for these experiments since airway epithelial
cells are exposed to ambient levels of oxygen in vivo, and while
C10 cells are immortalized, they do not form tumors in syngeneic
mice. Given that TR and TRX play important roles in the reduction
of PRXs, and that over-expression of TR is often associated with
resistance to oxidative stress and cell survival in tumor cells, we
examined the effects of expression of TR1 and TR2, with or
without expression of the cognate TRX, on recovery of C10 cells
from oxidative insults and cell survival. To examine the role of
selenocysteine in TR-mediated cell survival, expression of wild
type TR mRNAs were compared to TR mRNAs in which the codon
for the catalytic selenocysteine was replaced with the codon for
cysteine. To control for effects of non-coding sequences, plasmid
cDNA vectors expressing full-length mRNAs with native 50 and 30
untranslated regions, including the cognate selenocysteine inser-
tion element (SECIS element), were used.
Cellular TR activity is insensitive to oxidative insults
After exposure of C10 cells to concentrations of glucose oxidase
(GOx) greater than 2.5 mU/mL for 3 h, expression of cyclin D1
ceases and cells arrest in the cell cycle [32]. Exposure of C10 cells
to increasing concentration of GOx showed that concentrations of
1.25 mU/mL or greater induced hyperoxidation of PRXs (Fig. 1B,
lanes 1–6), whereas under the same exposure conditions GOx
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caused no signiﬁcant reduction of total cellular TR activity
(Fig. 1A). In contrast, exposure of C10 cells to the reactive aldehyde
acrolein, which attacks the selenocysteine moiety and thereby
inhibits TR activity [38], completely abolished cellular TR activity
(Fig. 1A). These data indicate that cellular TR activity, identical to
puriﬁed TR enzyme [6], is highly resistant to inactivation by
hydrogen peroxide, and that the vast majority of TR activity
detected in C10 cell lysates is sensitive to acrolein.
Under similar culture conditions exposure of C10 cells to highly
cytotoxic concentrations of menadione (MD), a quinone that
produces oxidative stress in both the cytoplasmic and mitochon-
drial compartments [39,40], resulted in increased levels of hyper-
oxidized PRX and modest reductions in TR activity, even at the
highest concentrations (Fig. 1C and D). At lower but cytostatic
doses of MD, increased hyperoxidation of PRXs was still evident
(Fig. 1E), but TR activity was completely unaffected (Fig. 1F). These
initial studies showed that under conditions in which PRXs
are inactivated by hyperoxidation, cellular TR activity is largely
unaffected, supporting the supposition that selenocysteine con-
tributes to the resistance of TR to inactivation by reactive oxygen
species [41].
Expression of Sec-TR and Cys-TR on total cellular TR activity
To mimic over-expression of TR that occurs in malignant
mesothelioma and other tumor cell types, plasmid expression
vectors were constructed for wild type human cytoplasmic TR
(Sec-TR1) and mitochondrial TR2 (Sec-TR2), as well as mutants in
which the codon for selenocysteine was replaced by site-directed
mutagenesis with a codon for cysteine (here referred to as Cys-TRs,
or TR1-U498C and TR2-U523C) (Fig. 2A). In transfection experi-
ments ectopic expression of immunoreactive TR1 polypeptides
was dependent on the concentration of plasmid DNA (Fig. 2B and
data not shown), and in C10 cells transfected with the WT TR1
expression vector (1 ug DNA/ 60 mm dish) total TR activity
increased 2-fold (Fig. 2C). In C10 cells transfected with the
expression vector for TR1-U498C levels of TR activity were not
signiﬁcantly greater than in C10 cells transfected with the
pCDNA3.1 vector alone (Fig. 2B and C). The increased TR1 protein
and activity levels after transfection of C10 cells with WT TR1
reﬂect those in malignant mesothelioma and other tumor cell
types [9]. Transfection of siRNAs targeted to TR1 reduced expres-
sion of TR1 by 90% (data not shown) and reduced TR activity to
10% of endogenous levels (Fig. 2C). Expression of WT-TR2 and TR2-
U523C at relatively high levels did not result in increased total
cellular TR activity (Fig. 2D), a ﬁnding in agreement with previous
studies that showed mitochondrial TR activity represents less than
10% of the total cellular TR activity [42], as suggested here by the
residual TR activity after silencing TR1 (Fig. 2C). Approximately
50% of the TR activity in control cells transfected with WT-TR1 or
TR1-U498C was sensitive to the TR inhibitor auranoﬁn (Fig. 2E).
We recognize that the amount of WT-TR1 protein expressed after
24 h was signiﬁcantly higher compared to endogenous levels, and
while the total TR activity also increased, it did not increase more
Fig. 1. Cellular TR activity is insensitive to oxidative insults. (A) TR activity in C10 cell lysates after treatment with 30 mM acrolein (Acr) for 1 h or the indicated concentrations
of glucose oxidase (GOx) for 3 h (n¼3, ***po0.001, ns¼not signiﬁcant). (B) Immunoblot analysis of hyper-oxidized PRXs in C10 cell lysates after treatment of cells with
indicated concentrations of GOx for 3 h. (C) TR activity was quantiﬁed in C10 cell lysates after acute treatment with the indicated concentrations of menadione (MD) for
45 min (n¼3, **po0.01). (D) Immunoblot analysis of TR1 expression levels and hyper-oxidized PRXs in cell lysates from (C). (E) TR activity was quantiﬁed in cell lysates
treated with low levels of MD overnight (n¼3). (F) Immunoblot analysis of TR1 expression levels and hyper-oxidized PRXs in cell lysates from (E). In panels B, D and F actin
was used as a loading control.
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than 2 to 3-fold. The reason for this apparent discrepancy is
not known.
These transfection studies established that the plasmid vectors
for WT-TR1 and Cys-TR1 mutants produced polypeptides with
apparent molecular weights indistinguishable from endogenous
TR, and that expression of Sec-TR1 increased cellular TR activity.
Expression of TR1-U498C, in contrast, failed to signiﬁcantly
increase cellular TR activity. Similarly expression of Sec-TR2 and
Cys-TR2 resulted in increased expression of immunoreactive TR2
polypeptides with apparent molecular weights identical to endo-
genous TR2, but neither Sec-TR2 nor TR2-U523C resulted in
statistically signiﬁcant increases to total cellular TR activity.
However, when mitochondrial fractions were prepared that con-
tained the ectopically expressed Sec-TR2, increased TR activity was
observed (data not shown). Co-transfection of TRX1 or TRX2 with
or without the cognate TR did not increase total TR activity above
that observed with transfection of TR alone (data not shown).
Effects of TR expression of reduction of roGFP
Using genetically-encoded GFP probes that are sensitive to
oxidation–reduction (roGFP) [33], the effects of expression of Sec
and Cys-TRs on the basal redox state of the cytoplasm and mitochon-
dria were investigated with ratiometric live cell imaging (Fig. 3A).
Fig. 2. Effects of expression of Sec and Cys containing TR1 and TR2 on total cellular TR activity. (A) Schematic depiction of Sec-TR (WT-TR1, WT-TR2) and Cys-TR (TR1-U498C
and TR2-U523C) expression vectors used in subsequent studies. U indicates selenocysteine and C cysteine. (B) Immunoblot analysis of cell lysates from C10 cells transfected
with the indicated expression vectors and blotted for TR1 (upper panel) or TR2 (lower panel). (C) Rate of NADPH consumption (A340, see Materials and methods) in lysates
from C10 cells transfected with the indicated TR1 expression vectors or with TR1-siRNA (left panel). TR activity from 3 replicate samples is summarized in the right panel
(**po0.01). (D) Rate of NADPH consumption measured at A340 of lysates from C10 cells transfected with the TR2 expression vectors (left panel); TR activity from 3 replicate
samples is summarized in the right panel. (E) TR activity in the indicated cell lysates with or without Auranoﬁn (Aur) (n¼3).
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For examining the redox state of the cytoplasm, C10 cells were co-
transfected with vectors for roGFP targeted to the cytoplasm (cyto-
roGFP) and either Sec-TR1 or Cys-TR1, with or without an expression
vector for TRX1. For mitochondria, C10 cells were transfected with
vectors for roGFP targeted to the mitochondria (mito-roGFP) and
either Sec-TR2 or Cys-TR2, with or without an expression vector for
TRX2. On the day following transfection, the ratio of oxidized to
reduced roGFP was evaluated by live cell ﬂuorescence microscopy
(Fig. 3A). Expression of Sec-TR1 but not Cys-TR1 reduced the basal
redox state of the cell cytoplasm (Fig. 3B), and in a similar fashion
expression of Sec-TR2 but not Cys-TR2 caused a signiﬁcant reduction
in the basal redox state of mitochondria (Fig. 3C and D). These results
correlated well with the effects of expression of Sec and Cys-TRs on
cellular TR activity (Fig. 2).
Cells co-transfected with vectors for roGFP and WT-TR1 or Cys-
TR1 (with or without expression of TRX1) were then exposed to
high concentrations of menadione for 30 min, followed by a
recovery period after the menadione was removed by 5 successive
changes of imaging medium, and ratiometric imaging was used to
assess changes in the roGFP oxidation state over time. As shown in
a representative experiment in Fig. 3E, roGFP was rapidly oxidized
in response to menadione, and the probe remained oxidized for at
least 25 min. Once the menadione was removed, the reduction of
the roGFP probe was rapid, with a return to basal state within 10–
15 min. In cells transfected with Sec-TR1 the change in the
oxidation (ΔOx) of the roGFP probe from oxidized to reduced
was increased over cells transfected with vector control or Cys-TR1
(Fig. 3F). In a similar fashion, expression of Sec-TR2 increased the
Fig. 3. Sec-TRs but not Cys-TRs accelerate roGFP reduction after oxidative insult. (A) Schematic of the dynamic response of the roGFP probe to changes in intracellular thiol
status. In the presence of oxidants a disulﬁde bond is formed in roGFP that increases ﬂuorescence intensity after excitation of the probe at 405 nm (Ox). Under reduced
conditions, ﬂuorescence intensity is increased after excitation at 488 nm (Red). The ratio of oxidized to reduced roGFP reﬂects cellular redox status. (B) Basal cytosolic redox
state in cells co-transfected with Cyto-roGFP, TRX1, and the indicated TR1 expression vectors (n¼20 cells). (C and D) Basal mitochondrial oxidation state in cells transfected
with Mito-roGFP, TRX2, and the indicated amount of TR2 expression vectors (n¼20, p value determined by students t-test). (E) The basal cellular redox state in C10 cells
expressing Cyto-roGFP was assessed by ratiometric imaging prior to adding 40 uM menadione (MD) for 20 min. After washing out MD by 5 exchanges with fresh imaging
media the same cells were re-examined over time to quantify change in oxidation (ΔOx, see Materials and methods) of the cyto-roGFP probe. (F) The experiment in panel E
was repeated in cells co-expressing the indicated TR1 expression vector and Cyto-roGFP, and the ΔOx was calculated post menadione washout after 10 min (n¼10,
*po0.05). (G) The experiment in E was repeated using cells co-transfected with Mito-roGFP and the indicated TR2 expression vectors and the ΔOx was calculated post
menadione washout after 10 min (n¼10, *po0.05).
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ΔOx of mito-roGFP after washout of menadione over cells trans-
fected with pcDNA (Fig. 3G). Expression of Cys-TR2 tended to
increase the ΔOx of the mito-roGFP, but the increases were not
statistically signiﬁcant across several experiments (Fig. 3G). The
ratiometric imaging data conﬁrmed that acute menadione expo-
sure induces both cytoplasmic and mitochondrial oxidative stress,
as reported previously [40], and that expression of Sec-TR1 or Sec-
TR2 reduces the basal redox state of C10 cells and improves
reduction of the roGFP probes targeted to the cytoplasm or
mitochondria, respectively.
TR and hyper-oxidation and reduction of PRXs
The peroxidatic cysteines of PRXs are among the most reactive
thiols in the cell [18]. To compare the oxidative modiﬁcations of
PRXs to oxidation of roGFP in response to menadione, cells were
treated with 40 mM menadione for 1 h, then the menadione was
washed out, and cells were allowed to recover for 4 h. Cell extracts
were prepared at various time points and assessed for the
presence of hyperoxidized PRXs by blotting with an antibody
speciﬁc to PRX-SO2/SO3H. A strip-reprobe blotting method was
used to estimate the relative amount of a speciﬁc PRX that was
inactivated by hyperoxidation [32]. To assess the levels of PRX-S-S-
PRX dimers, which can only be generated during the PRX catalytic
cycle, extracts were resolved under denaturing conditions in the
absence of reducing agent (i.e. with SDS but no DTT) [32]. Under
no exposure condition was a signiﬁcant reduction in the total
levels of PRX2-3 observed (Fig. 4, Supplementary Fig. 1).
The response of PRX3 to oxidative inactivation and reduction
during exposure and recovery is shown in Fig. 4, and this response
was representative of that for cytoplasmic PRX2 (Supplementary
Fig. 1). Within 1 h of menadione treatment, markedly increased
levels of hyper-oxidized PRXs were observed and expression of
WT-TR2 or TR2-U523C had no effect on oxidative inactivation of
PRXs, and reprobing the blot with antibody to PRX3 indicated a
signiﬁcant fraction of PRX3 was inactivated under these conditions
(Fig. 4A, lanes 4–6). Hyper-oxidized 2-Cys PRXs are repaired by
SRX, which is recruited to mitochondria in response to inactivation
of PRX3 [43]. Over time hyperoxidized PRXs were repaired, and
after 4 h the cellular pools of hyperoxidized PRXs had returned to
baseline, as did the signal for total PRX3 (Fig. 4A, lanes 7–17).
Although expression of WT-TR2 reduced the basal oxidation state
of cellular mitochondria (Fig. 3C), the change in basal redox state
did not affect either the inactivation of PRX3 by menadione or the
apparent rate of retro-reduction of hyperoxidized PRX3 by SRX.
The redox status of roGFP probes as compared to cellular proteins
is not well understood and may contribute to the interpretation of
this result [33].
Examination of the relative levels of PRX3 dimers by denatur-
ing but not reducing gel electrophoresis showed that increases in
hyperoxidized PRX3 (which cannot form disulﬁde-bonded dimers)
was accompanied by reduction in the abundance of PRX3 dimers,
as expected (Fig. 4B, lanes 4–6). After 2 h of recovery, levels of
PRX-SO2/SO3H were reduced, and levels of dimeric PRX3 were
increased as compared to baseline levels (Fig. 4B, compare lanes
1–3 to lanes 10–12). Expression of WT or TR2-U523C had no effect
on the level of PRX3 dimers or monomers by this time, but after
4 h of recovery expression of WT-TR2 increased the levels of both
dimers and monomers as compared to vector control or TR2-
U523C (Fig. 4 lanes 16–18). Together these expression experiments
showed that both mito-roGFP and PRX3 were rapidly oxidized in
response to menadione, but mito-roGFP was reduced in the order
of minutes whereas repair of hyperoxidized PRX3 occurred over
several hours. Only Sec containing WT-TR2 had any perceptible
effect on recovery from acute oxidative insult. Our results conﬁrm
the relative sensitivity of PRXs to inactivation by oxidants and
reinforce the concept that oxidative modiﬁcation of cellular pro-
teins depends in part on the reactivity of speciﬁc cysteine residues,
thereby providing a mechanistic basis for a hierarchy of modiﬁca-
tions in regulatory factors that mediate phenotypic outcomes.
Fig. 4. Hyper-oxidation and reduction of PRXs in response to ectopic expression of TR2. (A) C10 cells were transfected with indicated TR2 expression vectors (WT¼TR2,
U/C¼TR2-U523C) and the following day were treated with menadione (MD) for 1 h before exchange with fresh culture media. Cell lysates were prepared from control cells
(Ctrl), cells treated with MD for 1 h (MD), and cells allowed to recover for 1, 2, 3 or 4 h after removal of menadione. Cell lysates were prepared and separated by SDS-PAGE
under reducing conditions for immunoblot analysis to evaluate the levels of hyper-oxidized PRXs (PRX-SO2/SO3H). The blot was then stripped and reprobed with antibody to
PRX3 to speciﬁcally reveal the amount of hyper-oxidized PRX3 (see reference [27]). Note expression of TR2 did not inﬂuence retro-reduction of PRX3-SO2/SO3H by SRX.
(B) The extracts in (A) were resolved under denaturing but non-reducing conditions to evaluate PRX3-S-S-PRX3 dimers (D) and PRX3 monomers (M). All hyper-oxidized
PRX3 migrates as a monomer under both electrophoretic conditions because PRX3-SO2/SO3H cannot form disulﬁde bonds.
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Sec-TRs but not Cys-TRs improve cell survival
Acute oxidative insults invoke stress responses that differ from
chronic oxidative stress, and to model these conditions cells were
exposed to lower doses (60 nM–7.5 mM) of menadione for 24 h.
To evaluate the level of cellular oxidants after chronic exposure to
a range of menadione concentrations, we incubated cells with the
general oxidant probe DCF 24 h after addition of menadione to
cells. DCF ﬂuorescence showed that increasing concentrations of
menadione caused a corresponding continuous increase in cellular
oxidants for at least 24 h, and expression of either Sec-TR1 or TR1-
U498C did not reduce the levels of DCF ﬂuorescence (Fig. 5A). In
contrast, viability assays showed that expression of Sec-TR1
promoted cell survival and most likely cell proliferation above
control values for menadione concentrations up to 3.75 uM, above
which concentration cell viability was markedly reduced (Fig. 5B).
Note that low concentrations of menadione apparently stimulated
cell growth as suggested by increases in total cellular mass, and
that this effect was increased by expression of Sec-TR1, strength-
ening the possibility that enhanced production of oxidants and
elevated expression of TR1 in tumor cells cooperate to promote
cell proliferation.
Under similar conditions the expression of Sec-TR2 and TR2-
U523C unexpectedly tended to increase DCF ﬂuorescence (but not
signiﬁcantly) after 24 h (Fig. 5C), but only Sec-TR2 improved
viability at menadione concentrations between 0.5 and 3.75 uM
(Fig. 5D). Expression of TR2-U523C tended to increase viability,
especially at higher concentrations of menadione, but this effect
was not statistically signiﬁcant from experiment to experiment
(Fig. 5D). Co-expression of TRX1 with Sec-TR1 or TR1-U498C did
not improve viability above that observed with expression of WT-
TR1 alone (Fig. 5E), nor did co-expression of TRX2 with WT-TR2 or
TR2-U523C improve viability above that observed by expression of
WT-TR2 alone (Fig. 5F).
Discussion
The thioredoxin system comprised of TR, TRX and NADPH,
plays a complex role in cancer [12,44]. In normal cells TR is
thought to impede neoplastic transformation because it counter-
acts oxidative stress, but once cells are transformed, over-
expression of TR promotes tumor progression by protecting tumor
cells from elevated levels of endogenous oxidants [45]. We sought
to mimic these conditions by expressing TR1 and TR2 in non-
transformed but immortal mouse lung epithelial cells. To evaluate
the contribution of selenocysteine in TR to cell survival, we
compared the effects of expression of wild type cDNAs for TR1
and TR2 to cDNAs in which the codons for selenocysteine had been
changed to codons for cysteine. Gladyshev and colleagues have
Fig. 5. Overexpression of Sec-TRs but not Cys-TRs supports increased cell viability in response to low levels of oxidative stress. (A and C) C10 cells were transfected with the
indicated constructs, treated overnight with subcytotoxic concentrations of MD, and oxidant production was evaluated by monitoring DCF ﬂuorescence. Expression of any
isoform of TR1 or TR2 had no statistically signiﬁcant effect on the relative intensity of DCF ﬂuorescence by 24 h. (B and D) C10 cells were transfected with the indicated
expression vectors and cell viability after 24 h treatment with MD was quantiﬁed (*po0.05, WT-TR1 compared to pcDNA). (E and F) C10 cells were transfected with the
indicated TR expression vectors as in B and D, but in this instance with or without expression vectors for the cognate TRX. Cells were treated with the indicated
concentrations of MD and after 24 h cell viability was quantiﬁed. Note that expression of TRX1 or TRX2 alone, or with the cognate TR, did not improve viability over that
observed with expression of Sec-TR1 or Sec-TR2 alone.
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previously demonstrated that even with normal levels of dietary
selenium, cysteine is inserted at the Sec codon in approximately
10% of cellular TR1 [46]. How often Cys is incorporated instead of
Sec in TR1 in human malignancies is not known, and although
here the culture medium contained selenium, we did not inves-
tigate the ratio between Sec-TR and Cys-TR in untransfected C10
cells, or in cell transfected with various TR1 and TR2 expression
vectors. Rather we evaluated the relative expression levels of
various TR1 and TR2 polypeptides, their relationship to total TR
activity with and without oxidative insult, and their relative ability
to support cell viability under oxidative stress.
TR with selenocysteine in the active site is resistant to inactiva-
tion by a wide range of cellular oxidants in vitro [6]. In response to
extracellular ﬂuxes of hydrogen peroxide generated by glucose
oxidase, total cellular TR activity was unaffected (Fig. 1A), whereas
hyperoxidation of PRXs was readily evident (Fig. 1B). Treatment of
cells with menadione results in the production of intracellular
oxidants (Fig. 5A), but TR activity was diminished only after acute
exposure to very high, cytotoxic concentrations over short periods
of time (Fig. 1C). Overnight exposure to lower concentrations of
menadione that affected cell viability (e.g. 3.75 μM) did not affect
total cellular TR activity while hyperoxidation of PRXs was readily
evident (Fig. 1E and F). These data show that cellular TR is
insensitive to levels of intracellular and extracellular oxidants that
inﬂuence redox responsive signaling pathways and PRX oxidation
state and function. While in yeast inactivation of thiol peroxidase
by hyper-oxidation is required to conserve pools of reduced
thioredoxin for the repair of other oxidized proteins [47], hyper-
oxidation of PRXs may have more complex functions in mamma-
lian cells. For example, the oxidation state of PRXs is known to
govern interactions with regulatory factors [17]. In our previous
studies we observed that expression of cyclin D1 and recovery
from cell cycle arrest did not occur until hyperoxidized PRXs were
reduced [32]. Because inactivation of PRXs in response to oxidative
insult is rapid and recovery is slow, whereas TR activity is
unaffected, we suggest that TR sits at the top of a protein redox
pyramid that controls a hierarchy of responses to oxidative stress
(Fig. 6).
The C-terminal extension of 2-Cys PRXs is a structural feature
in eukaryotes that stabilizes the sulfenic acid intermediate and
promotes hyperoxidation. In stark contrast, we have proposed that
the chemistry of selenocysteine in the C-terminal redox center is
the structural feature of mammalian TR that renders the enzyme
resistant to inactivation by oxidative insult [48], thereby providing
an evolutionary advantage that permits TR to regulate a hierarchy
of responses to oxidative stress. While cellular TR contains a pool
of TR1 with cysteine in the C-terminal redox center, in viability
assays only Sec-TR1 or SecTR2 provided a survival advantage
(Fig. 5). The Cys mutant of TR1 has lower enzymatic activity
than WT TR1 containing selenocysteine [49], and may or may not
be more sensitive to oxidative inactivation. It is interesting to
note that over-expression of Cys-TR2 tended to enhance viability
under low menadione concentrations, yet this effect was not
statistically signiﬁcant. Two factors may contribute to the ability
of Cys-TR2 to support viability: (1) mitochondrial and cytosolic
redox potentials differ [50], and (2) the substrate speciﬁcity for
TR1 and TR2 differs [51]. Moreover, co-expression of TRX1 or TRX2
with its cognate reductase did not enhance survival, suggesting
the expression levels of TRX1 and TRX2 were not rate limiting
survival factors under these experimental conditions.
TR functions as a homodimer, and in the absence of stress we
observed no adverse effects from expressing Cys-TR1 or Cys-TR2
on cell viability, indicating these polypeptides do not exert a
dominant-negative phenotype or induce cell death via a SecTRAP
mechanism [15]. Together these studies support the hypothesis
that tumor cells maintain a pro-proliferative state under increased
oxidative stress through up-regulation of antioxidant networks,
and that over-expression of TR potentiates cell growth under
increased endogenous and exogenous oxidant levels [3]. Further,
selenocysteine in TR1 and TR2 may play an important role in cell
viability in response to oxidative insult by rendering both enzymes
insensitive to inactivation by oxidation [6].
Acknowledgments
This work was supported by NIH Grant GM094172, and BC was
supported by a graduate fellowship from the University of Ver-
mont Department of Pathology.
Appendix A. Supporting information
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.redox.2014.01.021.
References
[1] P.M. Burch, N.H. Heintz, Redox regulation of cell-cycle re-entry: cyclin D1 as a
primary target for the mitogenic effects of reactive oxygen and nitrogen
species, Antioxid. Redox Signal. 7 (5–6) (2005) 741–751.
[2] W.C. Burhans, N.H. Heintz, The cell cycle is a redox cycle: linking phase-
speciﬁc targets to cell fate, Free Radic. Biol. Med. 47 (9) (2009) 1282–1293.
[3] R.A. Cairns, I.S. Harris, T.W. Mak, Regulation of cancer cell metabolism, Nat.
Rev. Cancer 11 (2) (2011) 85–95.
[4] J. Lu, A. Holmgren, The thioredoxin antioxidant system, Free Radic. Biol. Med.
(2013).
[5] D. Mustacich, G. Powis, Thioredoxin reductase, Biochem. J. 346 (Pt 1) (2000)
1–8.
[6] G.W. Snider, et al., Selenocysteine Confers Resistance to Inactivation by
Oxidation in Thioredoxin Reductase: comparison of Selenium and Sulfur
Enzymes, Biochemistry (2013).
[7] K. Kahlos, et al., Up-regulation of thioredoxin and thioredoxin reductase in
human malignant pleural mesothelioma, Int. J. Cancer 95 (3) (2001) 198–204.
[8] V.L. Kinnula, P. Paakko, Y. Soini, Antioxidant enzymes and redox regulating
thiol proteins in malignancies of human lung, FEBS Lett. 569 (1–3) (2004) 1–6.
[9] K. Newick, et al., Peroxiredoxin 3 is a redox-dependent target of thiostrepton
in malignant mesothelioma cells, PLoS One 7 (6) (2012) e39404.
Fig. 6. TR sits at the top of a protein redox pyramid. We suggest selenocysteine
renders thioredoxin reductase insensitive to inactivation by oxidative insult and
permits it to regulate a hierarchy of responses via regulation of the oxidation state
of peroxiredoxins and other regulatory protein factors. In contrast, typical 2-Cys
mammalian peroxiredoxins have acquired evolutionary adaptations that render
them highly sensitive to inactivation by oxidation, and therefore are well suited to
function as intracellular redox sensors. The levels of TR affect the rate of reduction
of PRXs, but not the rate of inactivation, thereby contributing to survival in
response to chronic oxidative insults.
B. Cunniff et al. / Redox Biology 2 (2014) 475–484 483
[10] H.H. Zeng, L.H. Wang, Targeting thioredoxin reductase: anticancer agents and
chemopreventive compounds, Med. Chem. 6 (5) (2010) 286–297.
[11] J.D. Pennington, et al., Thioredoxin and thioredoxin reductase as redox-
sensitive molecular targets for cancer therapy, Curr. Pharm. Des. 13 (33)
(2007) 3368–3377.
[12] E.S. Arner, A. Holmgren, The thioredoxin system in cancer, Semin. Cancer Biol.
16 (6) (2006) 420–426.
[13] S. Gromer, et al., Human placenta thioredoxin reductase. Isolation of the
selenoenzyme, steady state kinetics, and inhibition by therapeutic gold
compounds, J. Biol. Chem. 273 (32) (1998) 20096–20101.
[14] M.P. Rigobello, et al., Gold complexes inhibit mitochondrial thioredoxin
reductase: consequences on mitochondrial functions, J. Inorg. Biochem. 98
(10) (2004) 1634–1641.
[15] K. Anestal, et al., Cell death by SecTRAPs: thioredoxin reductase as a
prooxidant killer of cells, PLoS One 3 (4) (2008) e1846.
[16] M. Mochizuki, et al., Thioredoxin regulates cell cycle via the ERK1/2-cyclin D1
pathway, Antioxid. Redox Signal. 11 (12) (2009) 2957–2971.
[17] L.B. Poole, A. Hall, K.J. Nelson, Overview of peroxiredoxins in oxidant defense
and redox regulation, Curr. Protoc. Toxicol. 7 (2011) 9 (Chapter 7).
[18] J.W. Baty, M.B. Hampton, C.C. Winterbourn, Proteomic detection of hydrogen
peroxide-sensitive thiol proteins in Jurkat cells, Biochem. J. 389 (Pt 3) (2005)
785–795.
[19] A. Hall, et al., Structural evidence that peroxiredoxin catalytic power is based
on transition-state stabilization, J. Mol. Biol. 402 (1) (2010) 194–209.
[20] L.B. Poole, A. Hall, K.J. Nelson, Overview of peroxiredoxins in oxidant defense
and redox regulation, Curr Protoc Toxicol 7 (2011) 9 (Chapter 7).
[21] A. Hall, P.A. Karplus, L.B. Poole, Typical 2-Cys peroxiredoxins–structures,
mechanisms and functions, FEBS J. 276 (9) (2009) 2469–2477.
[22] B. Biteau, J. Labarre, M.B. Toledano, ATP-dependent reduction of cysteine-
sulphinic acid by S. cerevisiae sulphiredoxin, Nature 425 (6961) (2003)
980–984.
[23] T.S. Chang, et al., Characterization of mammalian sulﬁredoxin and its reactiva-
tion of hyperoxidized peroxiredoxin through reduction of cysteine sulﬁnic
acid in the active site to cysteine, J. Biol. Chem. 279 (49) (2004) 50994–51001.
[24] S.G. Rhee, H.A. Woo, Multiple functions of peroxiredoxins: peroxidases,
sensors and regulators of the intracellular messenger H(2)O(2), and protein
chaperones, Antioxid. Redox Signal. 15 (3) (2011) 781–794.
[25] S. Barranco-Medina, J.J. Lazaro, K.J. Dietz, The oligomeric conformation of
peroxiredoxins links redox state to function, FEBS Lett. 583 (12) (2009)
1809–1816.
[26] C. Kumsta, U. Jakob, Redox-regulated chaperones, Biochemistry 48 (22) (2009)
4666–4676.
[27] M.B. Toledano, et al., The system biology of thiol redox system in Escherichia
coli and yeast: differential functions in oxidative stress, iron metabolism and
DNA synthesis, FEBS Lett. 581 (19) (2007) 3598–3607.
[28] J. Lee, et al., Yap1 and Skn7 control two specialized oxidative stress response
regulons in yeast, J. Biol. Chem. 274 (23) (1999) 16040–16046.
[29] T. Tachibana, et al., A major peroxiredoxin-induced activation of Yap1
transcription factor is mediated by reduction-sensitive disulﬁde bonds and
reveals a low level of transcriptional activation, J. Biol. Chem. 284 (7) (2009)
4464–4472.
[30] M.H. Yoo, et al., Thioredoxin reductase 1 deﬁciency reverses tumor phenotype
and tumorigenicity of lung carcinoma cells, J. Biol. Chem. 281 (19) (2006)
13005–13008.
[31] M.H. Yoo, et al., Targeting thioredoxin reductase 1 reduction in cancer cells
inhibits self-sufﬁcient growth and DNA replication, PLoS One 2 (10) (2007)
e1112.
[32] T.J. Phalen, et al., Oxidation state governs structural transitions in peroxir-
edoxin II that correlate with cell cycle arrest and recovery, J. Cell Biol. 175 (5)
(2006) 779–789.
[33] C.T. Dooley, et al., Imaging dynamic redox changes in mammalian cells with
green ﬂuorescent protein indicators, J. Biol. Chem. 279 (21) (2004)
22284–22293.
[34] B. Cunniff, et al., Mitochondrial-targeted nitroxides disrupt mitochondrial
architecture and inhibit expression of peroxiredoxin 3 and FOXM1 in malig-
nant mesothelioma cells, J. Cell Physiol. 228 (4) (2013) 835–845.
[35] B. Cunniff, et al., A direct and continuous assay for the determination of
thioredoxin reductase activity in cell lysates, Anal. Biochem. 443 (1) (2013) 34-40.
[36] P. Ranjan, et al., Redox-dependent expression of cyclin D1 and cell prolifera-
tion by Nox1 in mouse lung epithelial cells, Antioxid. Redox Signal. 8 (9–10)
(2006) 1447–1459.
[37] P. Ranjan, N.H. Heintz, S-phase arrest by reactive nitrogen species is bypassed
by okadaic acid, an inhibitor of protein phosphatases PP1/PP2A, Free Radic.
Biol. Med. 40 (2) (2006) 247–259.
[38] P.C. Spiess, et al., Proteomic proﬁling of acrolein adducts in human lung
epithelial cells, J. Proteomics 74 (11) (2011) 2380–2394.
[39] Y.Y. Chuang, et al., Gene expression after treatment with hydrogen peroxide,
menadione, or t-butyl hydroperoxide in breast cancer cells, Cancer Res. 62
(21) (2002) 6246–6254.
[40] G. Loor, et al., Menadione triggers cell death through ROS-dependent
mechanisms involving PARP activation without requiring apoptosis, Free
Radic. Biol. Med. 49 (12) (2010) 1925–1936.
[41] R.J. Hondal, E.L. Ruggles, Differing views of the role of selenium in thioredoxin
reductase, Amino Acids 41 (1) (2011) 73–89.
[42] A. Patenaude, M.R. Ven Murthy, M.E. Mirault, Mitochondrial thioredoxin
system: effects of TrxR2 overexpression on redox balance, cell growth, and
apoptosis, J. Biol. Chem. 279 (26) (2004) 27302–27314.
[43] Y.H. Noh, et al., Sulﬁredoxin translocation into mitochondria plays a crucial
role in reducing hyperoxidized peroxiredoxin III, J. Biol. Chem. 284 (13) (2009)
8470–8477.
[44] D.L. Hatﬁeld, et al., Selenoproteins that function in cancer prevention and
promotion, Biochim. Biophys. Acta 1790 (11) (2009) 1541–1545.
[45] D. Trachootham, et al., Selective killing of oncogenically transformed cells
through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate,
Cancer Cell 10 (3) (2006) 241–252.
[46] X.M. Xu, et al., Targeted insertion of cysteine by decoding UGA codons with
mammalian selenocysteine machinery, Proc. Natl. Acad. Sci. USA 107 (50)
(2010) 21430–21434.
[47] A.M. Day, et al., Inactivation of a peroxiredoxin by hydrogen peroxide is critical
for thioredoxin-mediated repair of oxidized proteins and cell survival, Mol.
Cell 45 (3) (2012) 398–408.
[48] R.J. Hondal, E.L. Ruggles, Differing views of the role of selenium in thioredoxin
reductase, Amino Acids 41 (1) (2010) 73–89.
[49] L. Zhong, A. Holmgren, Essential role of selenium in the catalytic activities of
mammalian thioredoxin reductase revealed by characterization of recombi-
nant enzymes with selenocysteine mutations, J. Biol. Chem. 275 (24) (2000)
18121–18128.
[50] D.P. Jones, Y.M. Go, Redox compartmentalization and cellular stress, Diabetes
Obes. Metab. 12 (Suppl. 2) (2010) S116–S125.
[51] O. Rackham, et al., Substrate and inhibitor speciﬁcities differ between human
cytosolic and mitochondrial thioredoxin reductases: implications for devel-
opment of speciﬁc inhibitors, Free Radic. Biol. Med. 50 (6) (2011) 689–699.
B. Cunniff et al. / Redox Biology 2 (2014) 475–484484
